Online citations, reference lists, and bibliographies.
← Back to Search

Noble Metals And Soft Bio-Inspired Nanoparticles In Retinal Diseases Treatment: A Perspective

Valeria De Matteis, Loris Rizzello
Published 2020 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
We are witnessing an exponential increase in the use of different nanomaterials in a plethora of biomedical fields. We are all aware of how nanoparticles (NPs) have influenced and revolutionized the way we supply drugs or how to use them as therapeutic agents thanks to their tunable physico-chemical properties. However, there is still a niche of applications where NP have not yet been widely explored. This is the field of ocular delivery and NP-based therapy, which characterizes the topic of the current review. In particular, many efforts are being made to develop nanosystems capable of reaching deeper sections of the eye such as the retina. Particular attention will be given here to noble metal (gold and silver), and to polymeric nanoparticles, systems consisting of lipid bilayers such as liposomes or vesicles based on nonionic surfactant. We will report here the most relevant literature on the use of different types of NPs for an efficient delivery of drugs and bio-macromolecules to the eyes or as active therapeutic tools.
This paper references
10.1016/j.ejps.2012.08.008
Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye.
R. C. Nagarwal (2012)
10.1016/J.POLYMER.2008.01.027
HYDROGELS IN DRUG DELIVERY: PROGRESS AND CHALLENGES
T. Hoare (2008)
10.1016/B978-0-08-102553-6.00004-0
Chitosan-based nanocarriers for ophthalmic applications
Rishi Paliwal (2019)
10.1016/J.EXER.2006.02.004
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
C. S. de Paiva (2006)
10.3390/pharmaceutics11090460
Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
E. B. Souto (2019)
10.1016/j.preteyeres.2010.08.002
Applications of nanoparticles in ophthalmology
Y. Diebold (2010)
10.18240/ijo.2018.06.23
Nanotechnology in retinal drug delivery.
S. Jiang (2018)
10.1038/s41598-019-48748-3
In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles
Anne-Laure Bailly (2019)
ISO International Organization for Standardization. Technical Specification: Nanotechnologies Terminology and Definitions for Nanoobjects Nanoparticle, Nanofibre and Nanoplate. ISO/TS 80004-2
10.1097/00006982-199515020-00026
Vascular Endothelial Growth Factor In Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
L. Aiello (1995)
10.3389/fbioe.2018.00170
Frontiers of Medical Micro/Nanorobotics: in vivo Applications and Commercialization Perspectives Toward Clinical Uses
F. Soto (2018)
10.1186/1477-3155-7-8
Silver nanoparticles inhibit VEGF-and IL-1β-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells
S. Sheikpranbabu (2009)
10.1038/s41598-017-03015-1
Comparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in mice
L. Yang (2017)
10.1016/j.addr.2017.12.009
Expression, activity and pharmacokinetic impact of ocular transporters☆
Kati-Sisko Vellonen (2018)
10.1016/j.ijpharm.2020.119020
New nanoparticles for topical ocular delivery of erythropoietin.
B. Silva (2020)
Niosomes as Nanoparticular Drug Carriers : Fundamentals and Recent Applications
D. A. Şeleci (2016)
10.1080/17458080.2010.547878
Size-based cytotoxicity of silver nanoparticles in bovine retinal endothelial cells
Muthu Irulappan Sriram (2012)
10.1038/nmat2162
Biosensing with plasmonic nanosensors.
Jeffrey N. Anker (2008)
10.1016/j.jconrel.2017.10.031
Injectable hydrogels for ophthalmic applications.
K. Wang (2017)
10.3109/03639045.2011.608191
Nanostructure-based drug delivery systems for brain targeting
S. Haque (2012)
10.1016/j.ijpharm.2015.07.053
Formulation and evaluation of cefuroxim loaded submicron particles for ophthalmic delivery.
Gabriela Andrei (2015)
10.1002/anie.200904359
Gold nanoparticles for biology and medicine.
D. Giljohann (2010)
Advances in Delivery Science and Technology
A Domb (2014)
Chitin and Chitosan: Production and Application of Versatile Biomedical Nanomaterials.
Daniel Elieh-Ali-Komi (2016)
10.1167/iovs.12-9955
EphA2 targeted doxorubicin stealth liposomes as a therapy system for choroidal neovascularization in rats.
J. Wang (2012)
10.1016/J.EURPOLYMJ.2017.12.004
Recent advances in smart hydrogels for biomedical applications: From self-assembly to functional approaches
N. N. Ferreira (2018)
10.1016/S0065-2423(10)50006-4
Ocular angiogenesis: mechanisms and recent advances in therapy.
M. Rajappa (2010)
10.1021/mp200394t
Nanomedicine(s) under the microscope.
R. Duncan (2011)
10.1016/J.JQSRT.2009.07.012
Optical properties and biomedical applications of plasmonic nanoparticles
N. Khlebtsov (2010)
10.3389/fphar.2019.01264
Recent Trends of the Bio-Inspired Nanoparticles in Cancer Theranostics
V. S. Madamsetty (2019)
10.1016/J.IJPHARM.2005.09.023
Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Ahmed S. Guinedi (2005)
10.1590/S0042-96862001000300011
Childhood blindness in the context of VISION 2020--the right to sight.
C. Gilbert (2001)
10.18632/oncotarget.23092
Doxorubicin-fucoidan-gold nanoparticles composite for dual-chemo-photothermal treatment on eye tumors
Hyejin Kim (2017)
10.1016/j.nano.2017.03.016
Intraocular application of gold nanodisks optically tuned for optical coherence tomography: inhibitory effect on retinal neovascularization without unbearable toxicity.
Hyun Beom Song (2017)
10.1007/s11095-008-9694-0
Recent Perspectives in Ocular Drug Delivery
Ripal Gaudana (2008)
10.1021/acs.molpharmaceut.6b00864
Effective Retinal Penetration of Lipophilic and Lipid-Conjugated Hydrophilic Agents Delivered by Engineered Liposomes.
J. Lee (2017)
10.1292/JVMS.11-0038
An evaluation of acute toxicity of colloidal silver nanoparticles.
Pattwat Maneewattanapinyo (2011)
10.1002/PPSC.201800464
Biodegradable Ultrasmall‐in‐Nano Gold Architectures: Mid‐Period In Vivo Distribution and Excretion Assessment
D. Cassano (2019)
10.1016/S1350-9462(97)00002-5
Ophthalmic drug delivery systems—Recent advances
C. L. Bourlais (1998)
10.1038/nature03987
Pathophysiological consequences of VEGF-induced vascular permeability
S. Weis (2005)
10.1371/journal.pone.0105359
Silver and Gold Nanoparticles Exposure to In Vitro Cultured Retina – Studies on Nanoparticle Internalization, Apoptosis, Oxidative Stress, Glial- and Microglial Activity
E. Söderstjerna (2014)
10.1002/ddr.21325
Berberine Hydrochloride Protects C2C12 Myoblast Cells Against Oxidative Stress‐Induced Damage via Induction of Nrf‐2‐Mediated HO‐1 Expression
Y. Choi (2016)
The Retina Retinal Diseases and VISION 2020
D. Yorston (2003)
10.1002/cmdc.201300371
Synthesis and Characterization of Glycol Chitosan DNA Nanoparticles for Retinal Gene Delivery
Rajendra N. Mitra (2014)
10.1016/0014-4835(85)90138-1
Kinetics of macromolecules injected into the subretinal space.
M. Marmor (1985)
10.3390/pharmaceutics4010197
Ocular Drug Delivery for Glaucoma Management
Nathan Gooch (2012)
10.3390/toxics5040029
Exposure to Inorganic Nanoparticles: Routes of Entry, Immune Response, Biodistribution and In Vitro/In Vivo Toxicity Evaluation
Valeria De Matteis (2017)
10.7860/JCDR/2015/10443.5394
Non viral vectors in gene therapy- an overview.
Murali Ramamoorth (2015)
10.1167/tvst.8.3.18
Photothermal Optical Coherence Tomography of Anti-Angiogenic Treatment in the Mouse Retina Using Gold Nanorods as Contrast Agents
Andrew Y. Gordon (2019)
10.1523/JNEUROSCI.23-04-01383.2003
Ectopic Photoreceptors and Cone Bipolar Cells in the Developing and Mature Retina
Emine Günhan (2003)
10.1016/j.biomaterials.2009.08.008
Antiangiogenic properties of silver nanoparticles.
S. Gurunathan (2009)
10.3109/17435390.2012.676099
Genotoxicity, acute oral and dermal toxicity, eye and dermal irritation and corrosion and skin sensitisation evaluation of silver nanoparticles
J. S. Kim (2013)
10.1038/nature10447
Bioinspired self-repairing slippery surfaces with pressure-stable omniphobicity
Tak-Sing Wong (2011)
10.1016/j.nano.2014.11.002
Negligible particle-specific toxicity mechanism of silver nanoparticles: the role of Ag+ ion release in the cytosol.
Valeria De Matteis (2015)
10.1021/es202417t
Mechanism of silver nanoparticle toxicity is dependent on dissolved silver and surface coating in Caenorhabditis elegans.
Xinyu Yang (2012)
Drug Delivery for Glaucoma Management
Nathan Gooch (2012)
10.1016/j.ijbiomac.2017.11.170
Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity.
Ameeduzzafar (2018)
10.3390/ijms18102076
Topical Ocular Delivery of TGF-β1 to the Back of the Eye: Implications in Age-Related Neurodegenerative Diseases
C. Platania (2017)
10.1038/nrm1524
Making sense of it all: bacterial chemotaxis
G. Wadhams (2004)
10.1039/C8BM00175H
Bio-inspired drug delivery systems: an emerging platform for targeted cancer therapy.
Gella Maelys Ngandeu Neubi (2018)
Singth, J. Green synthesis of silver nanoparticles using aqueous leaf extract of Premna integrifolia (L.) rich in polyphenols and evaluation of their antioxidant, antibacterial and cytotoxic activity
C. Singh (2019)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license
10.1016/j.ecoenv.2018.07.079
Silver nanoparticles affect lens rather than retina development in zebrafish embryos.
Yanjun Zhang (2018)
10.2119/molmed.2015.00073
Humanin Derivatives Inhibit Necrotic Cell Death in Neurons
A. Cohen (2015)
10.5681/bi.2011.003
Impacts of nanomedicines in ocular pharmacotherapy.
A. Nakhlband (2011)
10.1007/BF00192216
Development of the rabbit retina
A. Reichenbach (2004)
10.1016/j.ijpharm.2019.06.022
Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system.
Viliana Gugleva (2019)
10.1016/j.biomaterials.2014.08.019
Development and in vitro assessment of enzymatically-responsive poly(ethylene glycol) hydrogels for the delivery of therapeutic peptides.
Amy H. Van Hove (2014)
10.1016/j.visres.2017.05.009
The inner blood-retinal barrier: Cellular basis and development
Mónica Díaz-Coránguez (2017)
10.1016/j.jconrel.2012.12.013
Biocompatibility of engineered nanoparticles for drug delivery.
S. Naahidi (2013)
10.1126/sciadv.aat4388
A swarm of slippery micropropellers penetrates the vitreous body of the eye
Z. Wu (2018)
10.3390/nano9060884
Ocular Drug Delivery: A Special Focus on the Thermosensitive Approach
S. Sapino (2019)
10.1080/21691401.2016.1243545
Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation
J. Pandit (2017)
10.1016/J.CULT.2009.11.007
Basics and Clinical Applications of Photoacoustic Imaging
K. Valluru (2009)
10.1155/2013/590730
Effects of Naked Gold Nanoparticles on Proinflammatory Cytokines mRNA Expression in Rat Liver and Kidney
H. Khan (2013)
10.1021/acs.molpharmaceut.5b00828
Composite Nanoformulation Therapeutics for Long-Term Ocular Delivery of Macromolecules.
Vibhuti Agrahari (2016)
10.1073/PNAS.0405885101
Insect aquaplaning: Nepenthes pitcher plants capture prey with the peristome, a fully wettable water-lubricated anisotropic surface.
H. F. Bohn (2004)
10.1021/cr400295a
Chemical basis of interactions between engineered nanoparticles and biological systems.
Qingxin Mu (2014)
10.1242/dmm.017913
Biology and therapy of inherited retinal degenerative disease: insights from mouse models
Shobi Veleri (2015)
10.1038/eye.2013.107
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
K. G. Falavarjani (2013)
10.3389/fncel.2016.00020
Brain and Retinal Pericytes: Origin, Function and Role
A. Trost (2016)
10.1038/s41598-018-22112-3
Green synthesis of gold nanoparticles by thermophilic filamentous fungi
Z. Molnár (2018)
10.1016/j.ejpb.2014.12.028
Nanoparticle-based technologies for retinal gene therapy.
Jeffrey Adijanto (2015)
10.3390/ijms19092830
Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
Cheng-Han Tsai (2018)
10.1016/j.sjbs.2018.09.012
Size and time-dependent induction of proinflammatory cytokines expression in brains of mice treated with gold nanoparticles
Haseeb Ahmad Khan (2019)
10.2174/1381612825666190618155127
Engineered gold nanoshells killing tumour cells: new perspectives.
Valeria De Matteis (2019)
Nanotechnologies Terminology and Definitions for Nanoobjects Nanoparticle, Nanofibre and Nanoplate
ISO International Organization for Standardization. Te Specification (2020)
The Physiology of The Eye; Elsevier: Amsterdam
H. Davson (2012)
10.1007/s11051-016-3359-4
Evaluation of gold nanoparticles biocompatibility: a multiparametric study on cultured endothelial cells and macrophages
A. Orlando (2016)
10.1021/CR030698+
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology.
M. Daniel (2004)
10.1002/jcb.27415
Gold nanoparticle and polyethylene glycol in neural regeneration in the treatment of neurodegenerative diseases
Tayebe Aghaie (2019)
10.4103/2230-973X.143114
Investigation of moxifloxacin loaded chitosan–dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation
R. Kaskoos (2014)
10.1080/13102818.2019.1577699
Green synthesis of silver nanoparticles using aqueous leaf extract of Premna integrifolia (L.) rich in polyphenols and evaluation of their antioxidant, antibacterial and cytotoxic activity
C. Singh (2019)
Organ Stand Nanotechnologies Vocab Part 1 Core Terms ISO/TS 80004-12010
ISO (2010)
10.1016/j.drudis.2019.05.037
Hydrogels for sustained delivery of biologics to the back of the eye.
Debby P Chang (2019)
10.1056/NEJM199412013312203
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
L. Aiello (1994)
10.4103/0974-620X.200692
Applications of polymers in intraocular drug delivery systems
A. Alhalafi (2017)
10.1177/2041731418768285
Emerging properties of hydrogels in tissue engineering
J. Lee (2018)
Retinal Degeneration, Remodeling and Plasticity. In Webvision: The Organization of the Retina and Visual System; Salt Lake City (UT)
B. W. Jones (2016)
10.1136/bjo.35.3.184-a
The Physiology of the Eye
A. Churchill (1917)
10.1007/s11095-013-1195-0
The Effect of Glutathione as Chain Transfer Agent in PNIPAAm-Based Thermo-responsive Hydrogels for Controlled Release of Proteins
P. Drapala (2013)
10.3390/bios9020078
Silver-Based Plasmonic Nanoparticles for and Their Use in Biosensing
A. Loiseau (2019)
10.1080/13510002.1996.11747069
Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one.
Y. Yamamoto (1996)
10.1002/jps.23994
Enhanced doxorubicin delivery to the brain administered through glutathione PEGylated liposomal doxorubicin (2B3-101) as compared with generic Caelyx,(®)/Doxil(®)--a cerebral open flow microperfusion pilot study.
T. Birngruber (2014)
10.1016/j.cis.2018.11.008
Pharmaceutical applications of chitosan.
Z. Shariatinia (2019)
10.1016/B978-0-12-386509-0.00013-2
Gene delivery to the retina: from mouse to man.
J. Bennett (2012)
10.1039/C39940000801
Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system
M. Brust (1994)
10.3390/ijms21010109
The Inhibitory Effects of Gold Nanoparticles on VEGF-A-Induced Cell Migration in Choroid-Retina Endothelial Cells
C. Chan (2019)
10.1097/IAE.0b013e3180dc9360
ABSENCE OF HISTOLOGIC RETINAL TOXICITY OF INTRAVITREAL NANOGOLD IN A RABBIT MODEL
S. Bakri (2008)
10.1016/j.ejpb.2011.01.019
Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage.
K. Hironaka (2011)
10.1126/science.186.4162.449
Cyclic Guanosine Monophosphate: Elevation in Degenerating Photoreceptor Cells of the C3H Mouse Retina
D. Farber (1974)
10.1016/j.drudis.2019.03.004
Drug delivery to retinal photoreceptors
E. Himawan (2019)
Niosome ad a novel drug delivery system: A review
K G Das (2013)
10.1007/s12551-009-0024-5
The physics of flagellar motion of E. coli during chemotaxis
M. S. Kumar (2009)
10.1088/0957-4484/20/50/505101
Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity.
J. Kim (2009)
10.1007/978-3-319-72041-8_1
Toxicity Assessment in the Nanoparticle Era.
Valeria De Matteis (2018)
Nanotechnology in retinal drug
S. Jiang (2018)
10.1016/j.exer.2018.11.017
Thermosensitive chitosan‐gelatin‐based hydrogel containing curcumin‐loaded nanoparticles and latanoprost as a dual‐drug delivery system for glaucoma treatment
Yung-Hsin Cheng (2019)
10.1038/86684
A clearer vision for in vivo imaging
R. Weissleder (2001)
10.1002/smll.201303433
Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes.
Benjamin M. Davis (2014)
10.3109/1040841X.2014.912200
Silver nanoparticles: Synthesis methods, bio-applications and properties
E. Abbasi (2016)
10.1080/05704928.2017.1312427
Plasmonic nanoparticles and their analytical applications: A review
J. Boken (2017)
10.1016/0163-7258(89)90049-1
The pharmacology of antiglaucoma drugs.
M. F. Sugrue (1989)
10.1016/J.MATLET.2018.10.025
Green synthesis of gold nanoparticles using Croton Caudatus Geisel leaf extract and their biological studies
P. V. Kumar (2019)
10.1016/j.jconrel.2017.03.386
Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60
M. Mashal (2017)
10.1016/j.nano.2018.12.018
Non-viral vectors based on cationic niosomes and minicircle DNA technology enhance gene delivery efficiency for biomedical applications in retinal disorders.
I. Gallego (2019)
10.1007/s13346-018-0504-x
A stimulus-responsive, in situ-forming, nanoparticle-laden hydrogel for ocular drug delivery
M. Kabiri (2018)
10.2217/nnm-2018-0299
Gold nanoparticles for multimodal high-resolution imaging of transplanted cells for retinal replacement therapy.
Yoav Chemla (2019)
Guanylyl cyclases and signaling by cyclic GMP.
K. A. Lucas (2000)
10.1016/S1461-5347(98)00059-5
Pharmaceutical applications of chitosan
V. Dodane (1998)
10.1007/978-3-319-41129-3_2
Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications
Saurabh Bhatia (2016)
10.1021/CM100023P
TOXICITY OF SILVER NANOPARTICLES INCREASES DURING STORAGE BECAUSE OF SLOW DISSOLUTION UNDER RELEASE OF SILVER IONS
S. Kittler (2010)
10.1159/000431143
Routes for Drug Delivery to the Eye and Retina: Intravitreal Injections.
C. Meyer (2016)
10.1016/S1574-0641(06)80017-3
Chapter 11 - Single particle spectroscopic study on surface plasmon resonance probing local environmental conditions
T. Asahi (2006)
10.3923/IJP.2014.55.68
Chrysophanol Liposome Preconditioning Protects against Cerebral Ischemia-reperfusion Injury by Inhibiting Oxidative Stress and Apoptosis in Mice
J. Yan (2014)
10.1186/2040-2384-2-21
The potential of nanomedicine therapies to treat neovascular disease in the retina
Krysten M. Farjo (2010)
10.1167/IOVS.06-0830
Aqueous humor outflow: what do we know? Where will it lead us?
M. Fautsch (2006)
10.1186/s12951-019-0498-7
Liposomes for effective drug delivery to the ocular posterior chamber
Sisi Lai (2019)
10.1007/978-1-4614-9434-8_10
Nanotechnology-Based Ophthalmic Drug Delivery System
Fahima Dilnawaz (2014)
Properties and biomedical applications
K Y Lee (2012)
10.1039/DF9511100055
A study of the nucleation and growth processes in the synthesis of colloidal gold
J. Turkevich (1951)
10.1167/TVST.3.5.7
Novel Approaches for Retinal Drug and Gene Delivery.
S. Kim (2014)
Retinal Degeneration, Remodeling and Plasticity -- Webvision: The Organization of the Retina and Visual System
H. Kolb (1995)
10.1016/J.BIOMATERIALS.2006.11.028
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
Y. Diebold (2007)
10.1016/J.PROGPOLYMSCI.2011.06.003
Alginate: properties and biomedical applications.
K. Lee (2012)
10.1167/IOVS.06-0954
Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry.
D. Ghate (2007)
10.1016/j.preteyeres.2018.11.001
Transplantation of photoreceptors into the degenerative retina: Current state and future perspectives
Sylvia J. Gasparini (2018)
10.1111/j.1444-0938.2010.00553.x
Drug delivery to the posterior segment of the eye through hydrogel contact lenses
C. Schultz (2011)
10.3109/02713683.2015.1101140
Controlled and Extended In Vitro Release of Bioactive Anti-Vascular Endothelial Growth Factors from a Microsphere-Hydrogel Drug Delivery System
Christian Osswald (2016)
10.1155/2016/7372306
Niosomes as Nanoparticular Drug Carriers
D. A. Şeleci (2016)
10.1039/c3cs60218d
Nanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelines.
L. Rizzello (2014)
10.1002/emmm.201100126
Systemic low-molecular weight drug delivery to pre-selected neuronal regions
M. Campbell (2011)
10.1039/c0cs00078g
Rolled-up nanotech on polymers: from basic perception to self-propelled catalytic microengines.
Y. Mei (2011)
10.1021/NN301873V
Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration.
H. Yang (2012)
10.1016/j.mib.2015.12.001
Bacterial chemotaxis: information processing, thermodynamics, and behavior.
G. Micali (2016)
10.1016/J.OHC.2004.06.010
Anterior segment complications following periocular and intraocular injections.
A. Castellarin (2004)
Characteristics of the ocular fundus in primates.
L. Wolin (1967)
10.1016/j.jconrel.2016.03.012
Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation.
Fatemeh Ravar (2016)
10.1016/j.ejphar.2016.03.001
Targeting the complement system for the management of retinal inflammatory and degenerative diseases
H. Xu (2016)
10.2174/1567201815666181031163111
Humanin Nanoparticles for Reducing Pathological Factors Characteristic of Age-Related Macular Degeneration.
Aum Solanki (2019)
10.1136/bjo.85.12.1484
Socioeconomic status and blindness
R. Dandona (2001)
10.1517/17425247.1.1.99
Periocular routes for retinal drug delivery
Swita Raghava (2004)
10.1167/iovs.09-4373
Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes.
R. Zhang (2010)
10.1016/j.tiv.2016.08.013
Biocompatibility of gold nanoparticles in retinal pigment epithelial cell line.
Bedia Begüm Karakoçak (2016)
10.1073/pnas.1718792115
Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration
E. Vighi (2018)
10.5114/ceji.2019.87070
Therapeutic potential of curcumin in eye diseases
D. Radomska-Leśniewska (2019)
10.1016/J.IMPACT.2017.08.002
In vitro approaches to assess the hazard of nanomaterials
B. Drašler (2017)
10.3390/TOXICS5040029
Exposure to Inorganic Nanoparticles: Routes of Entry, Immune Response, Biodistribution and In Vitro/In Vivo Toxicity Evaluation.
V. D. Matteis (2017)
10.3390/s140405860
Synthesis of Silver Nanostructures by Multistep Methods
T. Zhang (2014)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar